Publications by authors named "Atse Huisman"

Claim this Profile
N
New opportunities for accessing promising non-oncological orphan drugs.
Carla E M Hollak, Carelle C Reparon-Schuijt, Kathelijn Verdeyen, Lisa J Deesker, Jaap W Groothoff, Atse H Huisman

Lancet Reg Health Eur· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines.
Atse H Huisman, Denise van den Berg, Saco de Visser, Bettina Ryll, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani

Front Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications.
Simone N Koole, Atse H Huisman, Lonneke Timmers, Hans M Westgeest, Edwin van Breugel

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant immune checkpoint blockade revisited.
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, Simone Koole, Lonneke Timmers

Lancet Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis